Investigating resistance of glioblastoma multiforme to radiotherapy and chemotherapy
<p>Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumour. Despite treatment with surgery, radiotherapy and temozolomide (TMZ) chemotherapy, patient survival remains poor, suggesting that GBM cells evade and resist these therapies. The insulin-like growth factor 1...
Main Author: | Simpson, A |
---|---|
Other Authors: | Macaulay, V |
Format: | Thesis |
Language: | English |
Published: |
2016
|
Subjects: |
Similar Items
-
Adjuvant uzatılmış temozolamid tedavisinin glioblastoma multiforme hastalarının sağkalımına etkisi
by: Berna YILDIRIM, et al.
Published: (2018-09-01) -
Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
by: Alexandre Ciuffi Faustino, et al.
Published: (2020-09-01) -
Glioblastoma Multiforme: A Single Hospital Experience
by: Hamid Behzadnia, et al.
Published: (2015-12-01) -
Hypofractionated radiotherapy part of multimodality treatment in multicentric glioblastoma multiforme: A case report
by: Vanessa Moldoveanu, et al.
Published: (2018-12-01) -
Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation
by: I. Frank Ciernik, et al.
Published: (2020-12-01)